Pivotal BioVenture Partners

Founded in 2016, Pivotal BioVenture Partners is a venture capital firm based in San Francisco. It invests in early-stage biotechnology companies focused on innovative therapeutic products and platforms across North America and Europe.

Joseph Charalel

Senior Associate

Meng Gao

Managing Partner

Rob Hopfner

Managing Partner

Robert Hopfner Ph.D

Managing Director

Ashish Khanna Ph.D

Partner

Ash Khanna

Partner

Jeni Lee

Partner

Simon Tsang

Operating Partner

Past deals in Macau

SanReno Therapeutics

Funding Round in 2021
SanReno Therapeutics is a biotechnology company that specializes in the development, manufacturing, and commercialization of therapies for kidney diseases and related conditions. Operating primarily in the People’s Republic of China, Hong Kong, Macau, Taiwan, and Singapore, the company is dedicated to advancing research and development in this therapeutic area. Formed as a joint venture between Chinook Therapeutics, Frazier Healthcare Partners, and Pivotal bioVenture Partners China, SanReno Therapeutics aims to create innovative solutions that enhance the quality of life for patients suffering from kidney-related ailments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.